Chinese Foreign Minister’s Unusual 12-Day Absence Draws Scrutiny
Chinese Foreign Minister Qin Gang has been absent from public view for 12 days, an usual absence for
2023-07-07 18:59
European Stocks Are Steady Before US Jobs Data; Miners Climb
European shares were little changed on Friday as investors awaited key US jobs data for further clues on
2023-07-07 18:47
Traders Brace for US Payrolls With Global Yields at 15-Year High
Bond investors are bracing for fresh signs of strength in the US labor market on Friday after Treasuries
2023-07-07 18:20
German Production Drops as Factory Weakness Weighs on Growth
German industrial production unexpectedly fell in May, casting a shadow over the recovery in Europe’s largest economy from
2023-07-07 14:22
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:16
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:30
Alphabet Exuberance Is Cooling on Wall Street After Stock’s Strong Run
Once one of the highest-rated stocks on Wall Street, Alphabet Inc. is getting a cooler reception from analysts
2023-07-06 21:48
Insight Partners raises $118 million fund to back underrepresented VCs
By Krystal Hu Global tech investor Insight Partners has raised $118 million in its second 20/20 Vision Capital
2023-07-06 20:15
Traders Lift Bets on BOE Hiking Interest Rate to 6.5% by March
Bets on the trajectory of the Bank of England’s key interest rate surged to the highest level in
2023-07-06 16:18
Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
2023-07-06 15:50